Date published: 2025-12-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

Flunisolide (CAS 3385-03-3)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
6-Fluoro-11,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide
CAS Number:
3385-03-3
Molecular Weight:
434.50
Molecular Formula:
C24H31FO6
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Flunisolide functions as a glucocorticoid receptor agonist, binding to cytoplasmic glucocorticoid receptors and subsequently translocating to the nucleus. There, it initiates the transcription of glucocorticoid-responsive genes, including lipocortins. These lipocortins act as inhibitors of phospholipase A2, effectively blocking the release of arachidonic acid from membrane phospholipids and halting the synthesis of inflammation-mediating prostaglandins and leukotrienes. Classified as a 21-hydroxysteroid, Flunisolide belongs to the group of organic compounds that carry a hydroxyl group at the 21-position of the steroid backbone.


Flunisolide (CAS 3385-03-3) References

  1. A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience.  |  Kantar, A., et al. 2007. Allergy Asthma Proc. 28: 671-87. PMID: 17883883
  2. Glucocorticoid receptor binding: a biphasic dependence on molecular size as revealed by the bilinear LinBiExp model.  |  Buchwald, P. 2008. Steroids. 73: 193-208. PMID: 18022656
  3. High-resolution mass spectrometric identification and quantification of glucocorticoid compounds in various wastewaters in the Netherlands.  |  Schriks, M., et al. 2010. Environ Sci Technol. 44: 4766-74. PMID: 20507090
  4. Modulation by flunisolide of tumor necrosis factor-alpha-induced stimulation of airway epithelial cell activities related to eosinophil inflammation.  |  Boero, S., et al. 2010. J Asthma. 47: 381-7. PMID: 20528590
  5. Olfactory drug effects approached from human-derived data.  |  Lötsch, J., et al. 2015. Drug Discov Today. 20: 1398-406. PMID: 26160059
  6. European demonstration program on the effect-based and chemical identification and monitoring of organic pollutants in European surface waters.  |  Tousova, Z., et al. 2017. Sci Total Environ. 601-602: 1849-1868. PMID: 28629112
  7. Intranasal Flunisolide Suppresses Pathological Alterations Caused by Silica Particles in the Lungs of Mice.  |  Ferreira, TPT., et al. 2020. Front Endocrinol (Lausanne). 11: 388. PMID: 32625168
  8. What makes flunisolide different among inhaled corticosteroids used for nebulization: a close look at the role of aqueous solubility.  |  Kantar, A. 2021. Multidiscip Respir Med. 16: 719. PMID: 33489120
  9. Supercritical CO2 Extraction of Organic Solvents from Flunisolide and Fluticasone Propionate.  |  Baldino, L., et al. 2021. Pharmaceutics. 13: PMID: 33922659
  10. Adsorption kinetics of 20 glucocorticoids at environmentally relevant concentrations in wastewater by powdered activated carbons and development of surrogate models.  |  Zhang, A., et al. 2022. J Water Process Eng. 50: 103279. PMID: 36349294
  11. Global occurrence of synthetic glucocorticoids and glucocorticoid receptor agonistic activity, and aquatic hazards in effluent discharges and freshwater systems.  |  Cole, AR. and Brooks, BW. 2023. Environ Pollut. 329: 121638. PMID: 37080519
  12. Disposition of flunisolide in the rat, mouse, dog, rhesus monkey, and cynomolgus monkey.  |  Chu, NI., et al. 1979. Drug Metab Dispos. 7: 81-9. PMID: 38078
  13. Variations in reproductive and developmental toxicant identification  |  Quigley, D., Simmons, F., Whyte, H., Robertson, J., & Freshwater, D. 2010. Journal of Chemical Health & Safety. 17(1): 29-53.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Flunisolide, 100 mg

sc-215039
100 mg
$110.00

Flunisolide, 500 mg

sc-215039A
500 mg
$434.00